American Oriental Bioengineering, Inc. (AOBI)
OTCMKTS · Delayed Price · Currency is USD
0.0012
+0.0001 (9.09%)
At close: Oct 20, 2025

American Oriental Bioengineering Company Description

American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of various pharmaceutical and healthcare products.

The company primarily provides prescription pharmaceutical products, including Shuanghuanglian Lyophilized Injection Powder under the SHL brand for the treatment of flu symptoms, such as high fever, cough, and sore throat, as well as upper respiratory infections, mild pneumonia, bronchitis, and tonsillitis; and Cease Enuresis Soft Gel under the CE Gel brand to alleviate bedwetting.

It also offers over-the-counter pharmaceutical products comprising Cease Enuresis Patch for the treatment of bedwetting and incontinence; Jinji Capsule for the treatment of endometritis, annexitis, and pelvic inflammations; Jinji Yimucao for the treatment of premenstrual syndrome (PMS) and other PMS and menopause-related symptoms; and Boke Nasal Spray for the treatment of sinus congestion from common cold, stuffy nose, chronic rhinitis, allergic rhinitis, and nasosinusitis.

In addition, the company provides various nutraceutical products, such as soybean peptide based drinks, tablets, powder, and instant coffee.

Further, it is involved in the wholesale and retail of pharmaceutical and nutraceutical products. The company sells its products directly and through distributors to hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical stores, and other retail outlets in the People’s Republic of China.

American Oriental Bioengineering, Inc. is headquartered in Beijing, China.

American Oriental Bioengineering, Inc.
American Oriental Bioengineering logo
Country United States
Industry Biotechnology
Sector Healthcare
Employees 3,719
CEO Shujun Liu

Contact Details

Address:
1 First Liangshuihe Avenue
Beijing, Nevada 100176
China
Phone 86 10 5982 2039

Stock Details

Ticker Symbol AOBI
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
ISIN Number US0287315032
SIC Code 2834

Key Executives

Name Position
Shujun Liu Founder, Chairman, Chief Executive Officer and President
Yanchun Li Founder, Chief Financial Officer, Secretary and Director
Jun Min Founder, Vice President, General Manager of HSPL and Director
Xiaopeng Xu Chief Operating Officer
Yan Gao Chief Accounting Officer
Yongxin Zhou Director of Sales
Ziyun Zhou General Manager of Human Resources